PeterIKarachunskiMD
Child Neurology • Minneapolis, MNAssociate Professor, Pediatric neurology University of Minnesota Medical School
Dr. Karachunski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
420 Delaware Street Se
Moos tower 13-240 MMC 295
Minneapolis, MN 55455Phone+1 612-626-2499Fax+1 612-273-0886
Education & Training
University of MinnesotaFellowship, Child Neurology, 2002 - 2005- University of MinnesotaResidency, Pediatrics, 2000 - 2003
Russian State Medical UniversityClass of 1987
Certifications & Licensure
MN State Medical License 2005 - 2025- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2005 Dec 01
- Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping Start of enrollment: 2012 Apr 01
- Finding the Optimum Regimen for Duchenne Muscular Dystrophy Start of enrollment: 2013 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Systemic under treatment of heart disease in patients with Duchenne muscular dystrophy.Peter Karachunski, DeWayne Townsend
Neuromuscular Disorders. 2023-10-01 - 1 citationsA comprehensive study of skeletal muscle imaging in FHL1-related reducing body myopathy.Payam Mohassel, Pomi Yun, Safoora Syeda, Abhinandan Batra, Andrew J Bradley
Annals of Clinical and Translational Neurology. 2023-08-01 - 7 citationsMeta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy.Perry B. Shieh, Gary Elfring, Panayiota Trifillis, Claudio Santos, Stuart W. Peltz
Journal of Comparative Effectiveness Research. 2021-10-25
Journal Articles
- TANGO2: Expanding the Clinical Phenotype and Spectrum of Pathogenic VariantsJennifer N Dines, Heather C Mefford, Barbara Burton, Joline Dalton, Alice Basinger, Peter Karachunski, Can Ficicioglu, Katherine L Helbig, Nature
Press Mentions
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingMay 26th, 2020
Toddler Who Got World’s Most Expensive Drug WalksFebruary 25th, 2020
Toddler with Fatal Muscle Condition ‘Recovers’ After $2m Infusion of World’s Most Expensive DrugFebruary 25th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
